Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cumberland Pharmaceuticals (CPIX) Other Gross PP&E Adjustments (2016 - 2025)

Cumberland Pharmaceuticals' Other Gross PP&E Adjustments history spans 15 years, with the latest figure at -$5.7 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 58.23% year-over-year to -$5.7 million; the TTM value through Dec 2025 reached -$5.7 million, down 58.23%, while the annual FY2025 figure was -$5.7 million, 58.23% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$5.7 million at Cumberland Pharmaceuticals, up from -$7.6 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $2.4 million in Q4 2021 and bottomed at -$7.6 million in Q3 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$4.9 million (2023), against an average of -$4.0 million.
  • The largest annual shift saw Other Gross PP&E Adjustments surged 102.35% in 2021 before it plummeted 2952.61% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $2.4 million in 2021, then plummeted by 246.65% to -$3.5 million in 2022, then plummeted by 92.56% to -$6.7 million in 2023, then surged by 46.54% to -$3.6 million in 2024, then crashed by 58.23% to -$5.7 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Other Gross PP&E Adjustments are -$5.7 million (Q4 2025), -$7.6 million (Q3 2025), and -$7.1 million (Q2 2025).